FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

10264711000001106: Clarelux 500micrograms/g foam (Pierre Fabre Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Oct 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2082961000001118 Clarelux 500micrograms/g foam (Pierre Fabre Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2082971000001111 Clarelux 500micrograms/g foam (Pierre Fabre Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
35439901000001110 Clarelux 500micrograms/g foam (3M Health Care Ltd, Pharmaceuticals Division) (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
35440001000001115 Clarelux 500micrograms/g foam (3M Health Care Ltd, Pharmaceuticals Division) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
41876301000001114 Clarelux 500micrograms/g foam (3M Health Care Ltd) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
42255801000001115 Clarelux 500micrograms/g foam (Pierre Fabre Ltd) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
48457801000001115 Clarelux 500micrograms/g foam (Pierre Fabre Dermo-Cosmetique) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Clarelux 500micrograms/g foam (Pierre Fabre Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Clarelux 500micrograms/g foam (Pierre Fabre Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Clarelux 500micrograms/g foam (Pierre Fabre Ltd) VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Clarelux 500micrograms/g foam (Pierre Fabre Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Clarelux 500micrograms/g foam (Pierre Fabre Ltd) Is a Product containing precisely clobetasol propionate 500 microgram/1 gram conventional release cutaneous foam true Inferred relationship Existential restriction modifier
Clarelux 500micrograms/g foam (Pierre Fabre Ltd) Has active ingredient Clobetasol propionate false Inferred relationship Existential restriction modifier
Clarelux 500micrograms/g foam (Pierre Fabre Ltd) Has active ingredient Glucocorticoid hormone false Inferred relationship Existential restriction modifier
Clarelux 500micrograms/g foam (Pierre Fabre Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Clarelux 500micrograms/g foam (Pierre Fabre Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Clarelux 500micrograms/g foam (Pierre Fabre Ltd) Has excipient Cetyl alcohol false Inferred relationship Existential restriction modifier
Clarelux 500micrograms/g foam (Pierre Fabre Ltd) Has excipient Stearyl alcohol false Inferred relationship Existential restriction modifier
Clarelux 500micrograms/g foam (Pierre Fabre Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Clarelux 500micrograms/g foam (Pierre Fabre Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Clarelux 500micrograms/g foam (Pierre Fabre Ltd) Has manufactured dose form Foam false Inferred relationship Existential restriction modifier
Clarelux 500micrograms/g foam (Pierre Fabre Ltd) Is a Clarelux true Inferred relationship Existential restriction modifier
Clarelux 500micrograms/g foam (Pierre Fabre Ltd) Has specific active ingredient Clobetasol propionate true Inferred relationship Existential restriction modifier
Clarelux 500micrograms/g foam (Pierre Fabre Ltd) Has dispensed dose form Foam true Inferred relationship Existential restriction modifier
Clarelux 500micrograms/g foam (Pierre Fabre Ltd) Has manufactured dose form Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Clarelux 500micrograms/g foam (Pierre Fabre Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Clarelux 500micrograms/g foam (Pierre Fabre Ltd) VMP non-availability indicator Not available false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Clarelux 500micrograms/g foam (Pierre Fabre Ltd) 100 gram Is pack of False Clarelux 500micrograms/g foam (Pierre Fabre Ltd) Inferred relationship Existential restriction modifier
Clarelux 500micrograms/g foam (Pierre Fabre Ltd) 100 gram Has AMP True Clarelux 500micrograms/g foam (Pierre Fabre Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start